Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yifei Zhang
Observed name:
Y Zhang
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
National Center for Toxicological Research,
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0009-0001-6517-7160
Observed ORCID:
0009-0001-6517-7160
OpenAlex ID:
A5024765475
Carbon nanotubes enhance the internalization of drugs by cancer cells and decrease their chemoresistance to cytostatics
2013
·
M Mahmood
, Y Xu
, et al.
·
Nanotechnology
·
33
Biomarker Utilization for Regulatory Decision Making: A Landscape Analysis of Neurological Drug Products Approved by FDA (2008–2024)
2025
·
Dahee Jung
, Sreedharan Sabarinath
, et al.
·
Clinical Pharmacology & Therapeutics
·
3
PDF
Perspective on Pharmacokinetic Comparability for Biologics Development
2026
·
Fei Tang
, Yifei Zhang
, et al.
·
Clinical Pharmacology & Therapeutics
·
1
PDF
Evolving landscape of drug development for pediatric rare diseases–from successes to strategies for addressing unmet needs
2026
·
Sydney Stern
, Yifei Zhang
, et al.
·
Journal of Pharmaceutical Sciences
Show more works
View as search
Works count:
4
Citation count:
37
H-index:
2
I10-index:
1
Year
Topic
Type